ASP Pharmacy Licensing & Compliance

First confirm that the business is retail of western medicines under an ASP, rather than treating “pharmacy” as a commercial term covering every type of medicine-related business. Registration under section 13 applies to specific premises used by an Authorised Seller of Poisons to store poisons for retail sale; the Board issues a certificate of registration of premises.

Statutory / licence position: an ASP operates at the western-medicine retail level. The Drug Office lists the “Certificate for Registration of Premises of an Authorized Seller of Poisons” separately from licences and subject areas for Listed Sellers of Poisons, wholesalers, manufacturers, dangerous drugs and antibiotics. If the proposed products, counterparties or supply model involve wholesale, import, export, manufacture, clinical trials or dangerous drugs, the ASP certificate alone cannot determine whether the required authorisation is in place.

Chinese medicines are not automatically included in an ASP merely because they are sold in the same shop. The Department of Health explains that Chinese medicines are regulated under the Chinese Medicine Ordinance (Cap. 549), with the Chinese Medicine Council of Hong Kong operating separate licensing pathways for retail / wholesale of Chinese herbal medicines and wholesale / manufacture of proprietary Chinese medicines. The project should first separate western-medicine SKUs, Chinese herbal medicines, proprietary Chinese medicines, health foods and non-medicinal goods, and then determine the applications and premises design required.

Drew Tang’s project recommendation: prepare a matrix of “business activity — product category — required licence / permit — premises” before entering into a lease, carrying out renovation, procuring products or signing a transaction. The matrix should distinguish retail, wholesale and import / export, and should not use shop signage or the company’s Business Registration name as a substitute for regulatory classification.

Swipe horizontally to view all items

Whether a product may be sold, who may sell it and whether a prescription is required depend on its actual classification under the Poisons List in the Pharmacy and Poisons Regulations and the relevant legislation, not merely its marketing name or description as “non-prescription”. Each product should be checked against its Hong Kong registration particulars, ingredients, dosage form and the lists applicable at the time.

Statutory sales boundaries: medicines that do not contain poisons may be sold at general retail outlets; products containing Part II poisons may be sold by an ASP or Listed Seller of Poisons. Products containing Part I poisons may be sold only at an ASP by a registered pharmacist personally, or under the pharmacist’s supervision and in their presence. Part I poisons listed in the Third Schedule require authorisation by prescription from a registered medical practitioner, registered dentist or registered veterinary surgeon. Antibiotics and dangerous drugs are also prescription drugs and are subject to additional statutory controls.

Product packaging is a first identification cue, not a substitute for classification checks. The Department of Health states that Part I poisons not listed in the Third Schedule should be labelled “Drug under Supervised Sales／监督售卖药物”, while poisons in the Third Schedule should be labelled “Prescription Drug／处方药物”. The supply of Part I poisons in the First Schedule, other than those in the Third Schedule, also involves keeping a poison book and recording purchaser details.

The pharmacy name and ℞ symbol are not merely general decorations either. Only an ASP may use names such as “pharmacy”, “dispensary”, “drug-store” or “藥房”, and only an ASP may arrange to display the statutory sign at its registered premises. The premises registration certificate, the name and registration certificate of the pharmacist responsible for professional activities, and the pharmacy’s business hours and the pharmacist’s duty hours must also be displayed prominently in the shop.

Swipe horizontally to view all items

The choice of entity should reflect the actual arrangements for business operations, the lease, employment, receipt of payments and control. ASP status is not restricted to limited companies, and company registration should not be confused with registration of the premises as if they were a single approval.

Under the Code’s definition, an ASP may be a registered pharmacist, a body corporate or an unincorporated body. The ASP application checklists currently linked from the Drug Office website require limited companies to submit registration and director details, sole proprietors to submit the relevant Business Registration details, and partnerships to submit the relevant partnership details. A Business Registration certificate is also required. Accordingly, the claim that “a limited company is the only eligible applicant entity” is inaccurate.

The application checklist requires details of the sole proprietor, partners, directors and employees, including their identities and positions, and declarations concerning their involvement in other wholesale dealers in western medicines, qualifications and relevant experience, references from previous employers, and any drug-related prosecutions or convictions. Declarations must be truthful and consistent. The actual structure must not be concealed through nominal directors, undisclosed actual operators or arrangements inconsistent with the lease.

The Board’s Code expressly identifies changes in proprietorship, partnership, directors and PIC as matters for which approval should be obtained in advance. Official public materials do not prescribe a uniform, automatic licence-transfer procedure for every company-level shareholding change. Where a transaction involves shareholders, control, nominee holdings or group restructuring, submit the structures before and after completion, together with details of the directors, PIC, pharmacist, premises and actual operating arrangements, to the Drug Office for case-specific confirmation.

Swipe horizontally to view all items

The PIC and registered pharmacist are both important roles, but they are not the same. Treating them as one role, describing the manufacturer’s Authorised Person (AP) as a mandatory position for an ASP, or delegating the pharmacist’s professional control to unregistered personnel can all create unnecessary compliance risks.

Statutory / Code roles: the ASP itself or the PIC assigned to operate the business must be a person whom the Board considers suitable. The application guidance provides for interviews with the PIC and pharmacist to assess their knowledge of the relevant legislation and the ASP Code of Practice. The registered pharmacist must exercise actual professional control over activities at the registered premises and is responsible for the personal control, supervision and dispensing of controlled medicines, and for applicable register entries.

The application checklist requires the registered pharmacist’s certificate of registration and practising certificate. A staffing plan should do more than list names: it should explain who is responsible for receiving goods, controlled-drug cabinet keys, prescription checks, dispensing, duty rosters, escalation of deviations, recalls, training and signing records. The pharmacist’s professional judgement should not be subject to improper commercial interference.

Staff may assist within the scope of their training and competence. However, the ASP must ensure that staff involved in the sale of medicines complete appropriate induction training, understand the statutory requirements for sales, receipt and storage, and have their training records kept at the registered premises. Staff experience does not remove the requirement for a registered pharmacist to be present and supervise transactions involving controlled medicines or prescriptions.

Swipe horizontally to view all items

“Not less than two-thirds of the opening hours on each day” is an express minimum requirement in the ASP Code of Practice. It is measured against the actual daily opening hours of the premises—not the proportion of staff, a weekly average, total monthly hours or mere telephone availability of a pharmacist.

Calculation under the Code: for each day the premises are open, multiply the actual opening hours by two-thirds to obtain the minimum hours for which a pharmacist must be present that day. For example, if the premises are open for nine hours, the minimum is six hours; if open for ten hours, it is six hours and 40 minutes; and if open for seven hours and 30 minutes, it is five hours. This is a minimum, not a target that may be rounded down, and excess attendance on one day cannot be carried over to make up a shortfall on another day.

During the hours counted towards the two-thirds requirement, the registered pharmacist must be at the registered premises and exercise control and supervision over employees. Management should keep records of opening hours, the pharmacist’s actual arrival and departure times, handovers, temporary closures and absences, so that the position on any day can be reconstructed. The pharmacy must also prominently display the pharmacist’s name, certificate of registration and duty hours, in a way that reflects the actual roster.

Cover and absence controls: another suitably qualified registered pharmacist may provide cover by being physically present, but a PIC, shop assistant, dispenser or pharmacist available remotely cannot replace the requirement for the pharmacist to be “present and supervising”. During any period when no registered pharmacist is physically present, controlled medicines must not be sold or supplied on the basis that they will be “checked later”. Controls should be established in advance for locking cabinets, suspending the relevant sales / dispensing, informing customers, record-keeping and escalation. Whether operations involving no controlled medicines may continue must still be assessed against product classification, display and actual operating arrangements.

Swipe horizontally to view all items

ASP approval and ongoing compliance centre on premises that can be inspected in practice. The floor plan, equipment list, on-site workflow, stock and record locations must be consistent with one another; submitting a plan does not remove the requirement for an inspection or subsequent maintenance.

The application checklist requires plans of the pharmacy as a whole and of the dispensing room, showing the total area, name and address. The current Code requires the dispensing area to provide sufficient space for the safe storage, handling, compounding and preparation of medicines, to be used only for dispensing, separated from other areas and protected against unauthorised access; customers must not enter the dispensing area. The materials reviewed do not specify a single minimum floor area in square metres applicable to all ASPs, so an industry rule of thumb should not be presented as a statutory area threshold.

The dispensing area should have adequate cleaning, lighting, air conditioning and suitable washing facilities. The Code specifies a water supply, sink and adequate drainage, as well as a dedicated source of distilled or boiled water for dispensing. Where the corresponding services are provided, the premises should also be equipped with suitable measures, mortars, pestles, spatulas, counting equipment and labelling facilities, together with access to up-to-date legislation and reference materials.

Cold-chain and locked storage are not optional decorative features. The Code requires a refrigerator in the dispensing area dedicated to medicines, capable of maintaining 2 to 8°C, lockable and fitted with a thermometer; food and drinks must not be stored in it. Part I poisons, antibiotics, psychotropic substances and dangerous drugs must be kept in a locked cabinet in the dispensing area, with the key held by the registered pharmacist present on the premises; dangerous drugs must also be kept in a separate cabinet.

Swipe horizontally to view all items

The key to an application pack is not the number of documents, but whether the applicant entity, personnel, premises, products and actual operating arrangements can substantiate one another. The official retail application portal provides both application materials and electronic forms. Before submission, refer to the website, electronic forms and Drug Office instructions current at that time.

The official application checklist covers the completed application form, Business Registration Certificate, incorporation or registration documents applicable to the type of entity (limited company, sole proprietorship or partnership), details of relevant persons and staff, statements of qualifications and experience, references from previous employers, declarations concerning the history of drug trading and drug-related prosecutions/convictions, staff appointment declarations, and proof of the registered pharmacist’s registration and practising status. The checklist requires a written explanation for any item that cannot be submitted.

Premises documents include floor plans of the pharmacy and dispensing area; the checklist requires the total area, shop name and address to be shown. As both interviews and site inspections verify “who does what, and where”, all document versions should consistently use the same entity name, address, PIC, registered pharmacist, product scope and effective date.

Drew Tang’s project recommendation: In addition to the official attachments, prepare a set of supporting-document drafts covering the product classification table, duty roster, role matrix, locked cabinets and key control, cold-chain records, prescription and record workflows, and SOPs for recalls and staff absence. These practical materials do not replace statutory documents; they provide actionable evidence to support interviews, inspections and subsequent operations.

Swipe horizontally to view all items

Official guidance states that, after application materials are submitted, interviews will be arranged for the PIC and pharmacist. Following a successful interview, a Pharmacist Inspector will inspect the premises, after which the application will be referred to the Pharmacy and Poisons Board (PPB) for consideration. Progress the process according to its dependencies, rather than submitting first and making the premises and staffing arrangements afterwards.

Before applying, finalise the applicant entity, registered premises, registered pharmacist, PIC, product scope, floor plan and supporting documents. After submission, the actual PIC and pharmacist should be able to explain their understanding of the legislation, the ASP Code of Practice, prescription dispensing, storage, records, staff training and handling of deviations. The actual responsible personnel cannot be replaced at interview by someone who handles paperwork only.

Before inspection, ensure that the premises are ready for a genuine demonstration: the dispensing area, refrigeration, locked cabinets, storage segregation, controlled medicines controls, displayed documents, reference materials and record arrangements should match the plans and declarations. If queries or requests for further information arise, link each issue to the relevant document, site location, responsible person and completion date. Avoid merely submitting an explanatory letter without correcting the actual arrangements.

Approval is determined by the Board on a case-by-case basis. The two-month service pledge in the current application form and guidance is conditional on the applicant and key personnel having good criminal and disciplinary records and sound financial standing, and on satisfactory results at the first interview assessment (if applicable) and first inspection. This pledge is not an unconditional or statutory guarantee of approval, nor does it cover leases, fitting-out works, recruitment, requests for additional documentation, transaction approvals or consultancy service periods.

Swipe horizontally to view all items

After a certificate is granted, compliance depends on whether procedures can be followed and reconstructed every day. The ASP Code of Practice brings controlled medicines, prescriptions, procurement, stock, recalls and registers together within the same set of on-site controls. Record retention periods and content should be implemented according to the medicine category and circumstances of each transaction.

Controlled medicines must not be made available for customers to select themselves and must remain in the dispensing area of the registered premises. Before supplying a First Schedule Part I poison (other than one in the Third Schedule), the Poisons Book must be completed with details including the buyer’s name, identity card number, address, occupation, purpose, medicine and quantity, and signed by the buyer and the registered pharmacist responsible for or supervising the sale. The Code of Practice provides an exception for emergency supplies to a buyer engaged in trade or business, subject to the buyer undertaking to provide a signed written order within forty-eight hours after delivery.

Prescription medicines must be dispensed by a registered pharmacist or under their supervision and in their presence. The Code of Practice requires the prescription to be checked for the prescriber, patient, quantity, dosage, date and other statutory particulars. After dispensing, an appropriate endorsement must be made on the prescription, and the prescription or a copy of a repeat prescription must be retained at the registered premises for two years. A different brand must not be substituted for the brand specified on the prescription unless this is consistent with the prescriber communication or prior brand-substitution arrangements described in the Code of Practice.

All registers, books, records and documents required to be kept must be held at the registered premises and be available for inspection at reasonable times. The Code of Practice requires books and records to be retained for two years from the date of the last entry. Supporting documents for antibiotics, Dangerous Drugs, the Poisons Book and the psychotropic substances register, as well as prescriptions and written purchase orders and invoices for controlled medicines, are also generally required under the relevant provisions to be retained for two years. Personal data should be handled in accordance with privacy legislation.

Swipe horizontally to view all items

Approval does not mean exemption from inspection. The Department of Health states that routine and random inspections of licensed premises are conducted, usually without prior notice. Premises may also be inspected when licence details change. Inspection readiness should be part of the daily system, not a last-minute exercise.

The Code of Practice requires ASPs to cooperate fully with inspectors in the performance of their statutory duties and not to obstruct staff from providing information required in connection with the identity of the proprietor. Inspectors may cross-check declarations against actual operations by examining premises layout, pharmacist attendance, the securing of controlled medicines, product labels and registration, cold chain, prescriptions, the Poisons Book, invoices, segregated goods, training, and complaint/recall records.

The authorities have not published a fixed self-inspection frequency applicable to all ASPs. Drew Tang’s practical recommendation is to establish a risk-based, documented schedule: check duty cover, locked cabinets, cold chain and suspect/expired stock daily; sample-check prescriptions, registers, training and batch numbers/expiry dates monthly; and have the PIC and registered pharmacist review the floor plan, product master file, personnel and change-trigger events quarterly. These are project-management recommendations and do not replace any statutory inspection frequency.

The common core of interviews and inspections is to “explain it clearly, show it on site and make it verifiable”. The PIC and registered pharmacist should be able to identify where each record is kept, who is responsible and when, and how to stop sales/quarantine/escalate when a deviation occurs, while ensuring that actual on-site practices remain consistent with the documents.

Swipe horizontally to view all items

Government fees, approval timelines, fitting-out and staffing costs, and third-party professional fees should be stated separately. Only amounts and timing references verified against current legislation or official notices should be expressed as figures. Capital, area or approval-day requirements with no uniform basis should not be invented.

According to Schedule 9 to the Pharmacy and Poisons Regulations (Cap. 138A), as verified on the date of checking, the registration fee for ASP premises is HK$1,000 and the renewal registration fee is HK$1,310. These are government fees and exclude rent, fitting-out, equipment, registered pharmacist staffing, legal/transaction support, consultancy services and corrective work arising from requests for further information. Before submission and renewal, the current e-legislation, payment notice and Drug Office instructions should still be checked.

The current ASP application form and guidance contain a conditional two-month service pledge: the applicant and key personnel must have good criminal and disciplinary records and sound financial standing, and must obtain satisfactory results at the first interview assessment (if applicable) and first inspection. This pledge is not an unconditional or statutorily guaranteed timeframe; complete documentation, interviews, inspections, requests for additional documentation, product scope and the Board's case-specific decisions all affect actual progress. Any project plan can only serve as a resource estimate and cannot promise regulatory approval.

The verified public application checklist requires the total floor area and premises conditions to be shown, but does not specify a minimum number of square metres or minimum paid-up capital applicable uniformly to all ASPs; this does not mean that financial standing is not assessed. Current application and renewal assessments consider the financial standing of the sole proprietor, partners, directors or PIC, as well as their qualifications, competence, skills and experience, and require truthful declarations concerning bankruptcy or voluntary arrangements with creditors, among other matters, as required by the current forms. Budgets should be modelled on intended product categories, cold chain requirements, locked cabinets, personnel, leases and actual risks, rather than promoted using unsupported “fixed thresholds”.

Swipe horizontally to view all items

Renewal is not just a matter of paying the fee. Before renewal and any change, proactively review whether the premises, pharmacist, PIC, directors, actual operations and records continue to meet the requirements.

Under the legislation, a certificate of registration of premises expires on the next 1 January after registration. An ASP may apply for renewal before expiry, and the Board may vary the original conditions at renewal. The Department of Health FAQ says that a renewal notice or payment notice is sent to the certificate holder one to two months before expiry; the holder should pay and collect the certificate as instructed. The actual expiry date and procedures are subject to the certificate, the current notice and the information for the individual case.

The Code requires an ASP to submit to the Secretary of the Board, every January, the address of each registered premises and a list of registered pharmacists who exercise personal control over those premises. Changes to licence-related matters, such as the company name, address or personnel, should be reported to the Department of Health’s Licensing and Compliance Division as soon as possible. The Drug Office FAQ specifically notes that some changes, such as the person responsible for poisons, may require approval.

Changes that more clearly require prior approval include changing the address or layout of registered premises, and changes in ownership, partnership, directors or PIC. Do not wait until after completing formalities with the Companies Registry or for Business Registration to notify the authorities of a relocation, refit or reconfiguration, sale of the business, change of partner, replacement of a director or PIC. Before implementation, check whether Board approval, an inspection, updated plans or a new application is required.

Swipe horizontally to view all items

An ASP certificate covers retail authorisation at specified premises. It does not mean that the product itself is registered or that the holder has wholesale or import/export authorisation. Manage product compliance, supply-chain qualifications and import/export documents for each consignment in parallel.

The Department of Health states that, before a drug is sold, offered for sale, distributed or possessed for sale or other such purposes in Hong Kong, it generally must be registered under section 36 of the Pharmacy and Poisons Regulations. The packaging should display a Hong Kong registration number in the form HK-XXXXX. A product’s availability overseas, supply by an overseas supplier or recognition in another market does not replace Hong Kong product registration or verification of its sales classification.

Pharmaceutical products must be purchased from licensed drug dealers. Controlled medicines must be purchased through written orders (including electronic orders); on receipt, goods must be checked against the written order, and product names, quantities, batch numbers and expiry dates must be checked against the sales invoice. Purchasing and record-keeping requirements for other products must still be determined according to applicable legislation, product categories and SOPs. ASPs must also maintain a product list classified according to legislation, specifying sales restrictions and storage requirements.

If conducting wholesale and/or import or export, the Department of Health states that an appropriate drug trader licence is required. Wholesale and/or import/export activities generally require a Wholesale Dealer Licence. An import licence (Form 3) or export licence (Form 6) must also be obtained for each consignment. Pharmacy procurement, storage, online sales, imports and supplies to other traders should therefore be checked against the specific transaction model; an ASP designation alone does not cover them all.

Swipe horizontally to view all items

When acquiring a pharmacy, first identify whether the transaction concerns shares, the business and assets, inventory, a lease, a change of address or an application for new premises. ASP premises registration, director/PIC arrangements, the actual control exercised by pharmacists and product records cannot be replaced by a company sale and purchase agreement alone.

Before completion, premises and licence due diligence should verify the certificate of registration of premises under section 13, expiry date, conditions, registered address, in-store display, floor plan, dispensing area, lockable cabinets, cold chain and consistency with the actual site. If the transaction involves relocation or a change of layout, make prior Board approval and any possible inspection a condition of completion or a controlled post-completion matter; do not assume that the existing certificate automatically moves with the premises.

For personnel and quality due diligence, verify the PIC, the registered pharmacist’s registration and current practising details, two-thirds daily duty coverage, employment/retention arrangements, prescriptions and registers, purchase invoices, inventory batch numbers and expiry dates, segregated goods, recalls, complaints, temperature deviations and outstanding remedial actions. No handover period should result in controlled medicines being sold without a pharmacist exercising actual control, gaps in records or uncertainty about inventory sources.

Transaction documents should set out enforceable conditions covering regulatory communications, prior approval for changes in ownership/partnership/directors/PIC, personnel transition, lease and premises, inventory count and classification, data and retention of records for two years, what happens if required confirmations are not obtained, and post-completion notifications. A 100% share acquisition may still require registration and changes to actual operations to be addressed. Conversely, an asset transaction or a newly established entity does not necessarily have only one possible route; the appropriate approach must be confirmed for each case.

Swipe horizontally to view all items